Literature DB >> 26384500

[Screening for cancer].

U Seifert1, U Schlanstedt-Jahn1, S J Klug2.   

Abstract

A low birth rate in addition to an increasing life expectancy within the context of an aging population characterize the current demographic situation in Germany. Cancer is primarily a disease of old age and the frequency increases with an expanding older population. In 2013, cancer was the second most common cause of death in Germany. With the aid of screening examinations cancer should be detected in the early stages so that suitable therapeutic measures can be initiated. In Germany, screening is currently offered for breast, cervical, colorectal, skin and prostate cancer and is covered by the statutory health insurance. Mammography screening is the only organized screening program in Germany. Eligible women are regularly invited to attend this program, which is not the case for the other types of cancer screening. In accordance with the Cancer Screening and Registry Act (KFRG) of 2013, colorectal and cervical cancer screening will also be implemented as organized screening programs in the future. As is the case in the mammography screening program, those eligible to participate will receive an invitation letter and the new programs are to be continually monitored, documented and evaluated.

Entities:  

Keywords:  Early detection of disease; Germany; Prevention; Risk factors; Screening

Mesh:

Year:  2015        PMID: 26384500     DOI: 10.1007/s00108-015-3738-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  12 in total

1.  Participation in cervical cancer screening in Germany.

Authors:  Stefanie J Klug; Katherine J Taylor; Ulrike Scheidemann-Wesp; Dagmar Lautz; Bernd Güther; Peter Potthoff; Maria Blettner
Journal:  Prev Med       Date:  2010-08-22       Impact factor: 4.018

2.  Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: analyses based on 4,407,971 screening colonoscopies.

Authors:  Hermann Brenner; Lutz Altenhofen; Christian Stock; Michael Hoffmeister
Journal:  Eur J Cancer       Date:  2015-04-20       Impact factor: 9.162

Review 3.  Prevention and early detection of prostate cancer.

Authors:  Jack Cuzick; Mangesh A Thorat; Gerald Andriole; Otis W Brawley; Powel H Brown; Zoran Culig; Rosalind A Eeles; Leslie G Ford; Freddie C Hamdy; Lars Holmberg; Dragan Ilic; Timothy J Key; Carlo La Vecchia; Hans Lilja; Michael Marberger; Frank L Meyskens; Lori M Minasian; Chris Parker; Howard L Parnes; Sven Perner; Harry Rittenhouse; Jack Schalken; Hans-Peter Schmid; Bernd J Schmitz-Dräger; Fritz H Schröder; Arnulf Stenzl; Bertrand Tombal; Timothy J Wilt; Alicja Wolk
Journal:  Lancet Oncol       Date:  2014-10       Impact factor: 41.316

4.  The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain.

Authors:  N Muñoz; F X Bosch; S de Sanjosé; L Tafur; I Izarzugaza; M Gili; P Viladiu; C Navarro; C Martos; N Ascunce
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

5.  [Participation in cancer screening in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  A Starker; A-C Saß
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

Review 6.  Colorectal cancer.

Authors:  Hermann Brenner; Matthias Kloor; Christian Peter Pox
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

Review 7.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Authors:  Xavier Castellsagué; Nubia Muñoz
Journal:  J Natl Cancer Inst Monogr       Date:  2003

Review 8.  Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Authors:  Marc Arbyn; Guglielmo Ronco; Ahti Anttila; Chris J L M Meijer; Mario Poljak; Gina Ogilvie; George Koliopoulos; Pontus Naucler; Rengaswamy Sankaranarayanan; Julian Peto
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

Review 9.  Screening for breast cancer with mammography.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

10.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

Authors:  Guglielmo Ronco; Joakim Dillner; K Miriam Elfström; Sara Tunesi; Peter J F Snijders; Marc Arbyn; Henry Kitchener; Nereo Segnan; Clare Gilham; Paolo Giorgi-Rossi; Johannes Berkhof; Julian Peto; Chris J L M Meijer
Journal:  Lancet       Date:  2013-11-03       Impact factor: 79.321

View more
  3 in total

Review 1.  α7 nicotinic acetylcholine receptors in lung cancer.

Authors:  Shengchao Wang; Yue Hu
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

Review 2.  [Screening for cervical and breast cancer].

Authors:  J Wilm; S Schüler-Toprak; O Ortmann
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

3.  Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.

Authors:  Sheng Yang; Jing Sui; Geyu Liang
Journal:  PeerJ       Date:  2017-11-30       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.